Physical stress testing of insulin suspensions and solutions

被引:14
作者
Shnek, DR [1 ]
Hostettler, DL [1 ]
Bell, MA [1 ]
Olinger, JM [1 ]
Frank, BH [1 ]
机构
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
D O I
10.1021/js980074x
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Insulin pen-cartridge devices have evolved in order to increase patient compliance and convenience of use in a portable, multiple dosage device. With the advent of a portable insulin containing device, stability considerations have evolved from standard chemical indicators to include the effects of temperature and agitation on physical characteristics. To address these issues, two automated physical stress tests were developed based on market research data and input from regulatory authorities to understand the effect of thermomechanical stress on the product. First, the temperature cycling and resuspension test (TCRT) includes temperature cycling (25-37 degrees C) combined with agitation. The high temperature and extreme agitation test (HTEAT) includes continuous high temperature (37 degrees C) exposure combined with 4 h daily agitation. The total stress exposure is a function of the temperature, agitation, and time. The tests range from moderate stress (TCRT) to considerable stress (HTEAT) determined from the number of cartridge inversions and average daily temperature. Physical stress testing of both insulin suspensions and solution formulations in cartridges were performed and interpreted with respect to multiple endpoints. For suspensions, prolonged exposure to extreme stress caused the protein to form agglomerates, either in the suspension or adhered to the cartridge walls. In contrast, protein solutions subjected to the same extreme stress conditions did not exhibit any Visually detectable change. Visual changes in the product under physical stress conditions can increase dose-potency result variability as well as exhibit acid-insoluble aggregates.
引用
收藏
页码:1459 / 1465
页数:7
相关论文
共 9 条
[1]   Effect of patient-selected intensive insulin therapy on quality of life [J].
Chantelau, E ;
Schiffers, T ;
Schutze, J ;
Hansen, B .
PATIENT EDUCATION AND COUNSELING, 1997, 30 (02) :167-173
[2]   SAFETY, EFFICACY, ACCEPTABILITY OF A PRE-FILLED INSULIN PEN IN DIABETIC-PATIENTS OVER 60 YEARS OLD [J].
COSCELLI, C ;
LOSTIA, S ;
LUNETTA, M ;
NOSARI, I ;
CORONEL, GA .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1995, 28 (03) :173-177
[3]  
*E LILL CO, 1996, INF PAT
[4]   Pharmacokinetic considerations of new insulin formulations and routes of administration [J].
Hoffman, A ;
Ziv, E .
CLINICAL PHARMACOKINETICS, 1997, 33 (04) :285-301
[5]  
HOSTETTLER D, 1997, UNPUB
[6]  
KIRSCH ES, 1996, HAREFUAH, V130, P604
[7]   PRE-MIXED INSULIN DELIVERED BY DISPOSABLE PEN IN THE MANAGEMENT OF CHILDREN WITH DIABETES [J].
OHAGAN, M ;
GREENE, SA .
DIABETIC MEDICINE, 1993, 10 (10) :972-975
[8]   MULTIPLE INSULIN INJECTION THERAPY USING AN INSULIN PEN - WHO BENEFITS - A CLINICAL 3-YEAR FOLLOW-UP-STUDY OF 100 TYPE-1 AND 51 TYPE-2 DIABETIC-PATIENTS [J].
ROSENGREN, A ;
ADLERBERTH, A ;
BRESATER, LE ;
EHNBERG, S ;
WELIN, L .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1993, 20 (01) :69-74
[9]  
1993, UNPUB INTERNAL LILLY